Feifei Cheng

1.1k total citations
21 papers, 736 citations indexed

About

Feifei Cheng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Feifei Cheng has authored 21 papers receiving a total of 736 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Feifei Cheng's work include Cancer Cells and Metastasis (4 papers), Enzyme Catalysis and Immobilization (3 papers) and Retinal Development and Disorders (3 papers). Feifei Cheng is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Enzyme Catalysis and Immobilization (3 papers) and Retinal Development and Disorders (3 papers). Feifei Cheng collaborates with scholars based in China, Australia and United States. Feifei Cheng's co-authors include Cheng Qian, Li Su, Zi‐Bing Jin, Limei Liu, Juanjuan Shan, Jun Chen, Junjie Shen, Xue‐Bi Cai, Chungang Liu and Lupin Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.

In The Last Decade

Feifei Cheng

21 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feifei Cheng China 12 415 320 172 112 75 21 736
Guangzhi Wang China 18 490 1.2× 314 1.0× 160 0.9× 103 0.9× 41 0.5× 49 909
Chaoju Gong China 14 364 0.9× 216 0.7× 211 1.2× 80 0.7× 73 1.0× 28 619
Changwen Jing China 15 301 0.7× 275 0.9× 154 0.9× 143 1.3× 44 0.6× 32 582
Eva Obermayr Austria 15 327 0.8× 481 1.5× 508 3.0× 144 1.3× 45 0.6× 44 953
Junhye Kwon South Korea 18 594 1.4× 205 0.6× 274 1.6× 93 0.8× 55 0.7× 31 854
Bin Gui China 21 850 2.0× 242 0.8× 295 1.7× 192 1.7× 41 0.5× 46 1.3k
Arnaud Blomme Belgium 14 402 1.0× 174 0.5× 188 1.1× 83 0.7× 30 0.4× 21 736
Sherry A. Weppler Netherlands 10 504 1.2× 307 1.0× 144 0.8× 80 0.7× 27 0.4× 11 836
Matthias Sommer United States 10 416 1.0× 115 0.4× 223 1.3× 55 0.5× 27 0.4× 14 639

Countries citing papers authored by Feifei Cheng

Since Specialization
Citations

This map shows the geographic impact of Feifei Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Cheng more than expected).

Fields of papers citing papers by Feifei Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Cheng. The network helps show where Feifei Cheng may publish in the future.

Co-authorship network of co-authors of Feifei Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Feifei Cheng. A scholar is included among the top collaborators of Feifei Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feifei Cheng. Feifei Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Feifei, Zhili Zheng, Xiaoman Li, et al.. (2025). Distinct methylomic signatures of high-altitude acclimatization and adaptation in the Tibetan Plateau. Cell Discovery. 11(1). 45–45. 2 indexed citations
2.
Huang, Chuiguo, Noel Ng, Claudia H.T. Tam, et al.. (2025). Shortened Relative Leukocyte Telomere Length Is Associated With Polycystic Ovary Syndrome and Metabolic Traits. Endocrinology Diabetes & Metabolism. 8(2). e70030–e70030. 1 indexed citations
3.
Hatton, Alesha, Feifei Cheng, Tian Lin, et al.. (2024). Genetic control of DNA methylation is largely shared across European and East Asian populations. Nature Communications. 15(1). 2713–2713. 5 indexed citations
4.
Cheng, Feifei, Jin He, & Jing Yang. (2023). Bone marrow microenvironment: roles and therapeutic implications in obesity-associated cancer. Trends in cancer. 9(7). 566–577. 1 indexed citations
5.
Cheng, Feifei, Yi‐Shiou Chiou, Yan Qin Tan, et al.. (2022). Trefoil factor 3 promotes pancreatic carcinoma progression via WNT pathway activation mediated by enhanced WNT ligand expression. Cell Death and Disease. 13(3). 265–265. 16 indexed citations
6.
Chen, Shihao, et al.. (2021). Genetic Screening Revealed Latent Keratoconus in Asymptomatic Individuals. Frontiers in Cell and Developmental Biology. 9. 650344–650344. 12 indexed citations
8.
9.
Huang, Xiu‐Feng, Lue Xiang, Cheng Wan, et al.. (2018). Mutation of IPO13 causes recessive ocular coloboma, microphthalmia, and cataract. Experimental & Molecular Medicine. 50(4). 1–11. 18 indexed citations
10.
Zhang, Yinjun, et al.. (2018). The enzymatic resolution of 1‐(4‐chlorophenyl)ethylamine by Novozym 435 to prepare a novel triazolopyrimidine herbicide. Chirality. 30(11). 1225–1232. 8 indexed citations
11.
12.
Xiang, Lue, Xue‐Jiao Chen, Kun‐Chao Wu, et al.. (2017). miR-183/96 plays a pivotal regulatory role in mouse photoreceptor maturation and maintenance. Proceedings of the National Academy of Sciences. 114(24). 6376–6381. 67 indexed citations
13.
Cai, Xue‐Bi, Feifei Cheng, Cheng Wan, et al.. (2017). Mutations in LRP5 , FZD4 , TSPAN12 , NDP , ZNF408 , or KIF11 Genes Account for 38.7% of Chinese Patients With Familial Exudative Vitreoretinopathy. Investigative Ophthalmology & Visual Science. 58(5). 2623–2623. 56 indexed citations
14.
Huang, Xiu‐Feng, Zhiqin Huang, Feifei Cheng, et al.. (2017). Genome-Wide Detection of Copy Number Variations in Unsolved Inherited Retinal Disease. Investigative Ophthalmology & Visual Science. 58(1). 424–424. 22 indexed citations
15.
Su, Li, Yongli Luo, Zhi Yang, et al.. (2016). MEF2D Transduces Microenvironment Stimuli to ZEB1 to Promote Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer. Cancer Research. 76(17). 5054–5067. 57 indexed citations
16.
Cheng, Feifei, Li Su, Chao Yao, et al.. (2016). SIRT1 promotes epithelial–mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Letters. 375(2). 274–283. 84 indexed citations
17.
Cheng, Feifei, Anzhou Ma, Xuliang Zhuang, Xiaojia He, & Guoqiang Zhuang. (2016). N-(3-oxo-hexanoyl)-homoserine lactone has a critical contribution to the quorum-sensing-dependent regulation in phytopathogenPseudomonas syringae pv. tabaci11528. FEMS Microbiology Letters. 363(23). fnw265–fnw265. 10 indexed citations
18.
Liu, Zhen, Zhongyuan Huang, Feifei Cheng, et al.. (2016). Efficient Dual-Site Carbon Monoxide Electro-Catalysts via Interfacial Nano-Engineering. Scientific Reports. 6(1). 33127–33127. 9 indexed citations
19.
Luo, Yongli, Zhi Yang, Li Su, et al.. (2016). Non-CSCs nourish CSCs through interleukin-17E-mediated activation of NF-κB and JAK/STAT3 signaling in human hepatocellular carcinoma. Cancer Letters. 375(2). 390–399. 38 indexed citations
20.
Cheng, Feifei, Li Su, & Cheng Qian. (2016). Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 7(30). 48832–48841. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026